The availability of user-friendly, disposable, and low-cost elastomeric infusion pumps
Companies in the elastomeric infusion pumps market are focused on manufacturing user-friendly elastomeric infusion pumps with flow sensors and regulators for the accurate measurement of drug delivery rates. Moreover, some companies, as a part of their strategy to capture a larger market share, are launching elastomeric infusion pumps with additional features.
For example, Fluonic. Inc. launched SURE+ product, a fully disposable pump that can regulate drug flow. SURE+ is built on the framework of a common inexpensive elastomeric infusion pump, with the addition of a fluonic flow sensor and regulator.
Rapid industrialization in emerging economies in the East African belt, Eastern Europe, and Asia Pacific regions is supporting the production and R&D of low-cost medical devices. The availability of a well-developed manufacturing infrastructure, low-cost labour, and trained technicians in countries such as China are also among factors supporting growth of the market.
Companies that manufacture elastomeric infusion pumps, such as Baxter and B. Braun Melsungen AG, have R&D centres as well as manufacturing divisions based in emerging economies such as India, Brazil, and China. Not only is this strategy profitable, but also results in an increase in the sales of elastomeric infusion pumps in these high-growth markets.
Find Out More about the Report Coverage
- Baxter International, Inc.
- Fresenius Kabi AG
- B. Braun Melsungen AG
- Ambu A/S
- Leventon, S.A.U.
- Nipro Corporation
- Terumo Corporation
- Avanos Medical, Inc.
Fragmented market with the presence of few established brands and several local players
The global elastomeric infusion pumps market is fragmented in nature, with the prevalence of oligopolistic competition among few renowned brands in the market. Following the patent cliff in the elastomeric infusion pumps market, established manufacturers are exploring newer opportunities for revenue generation. Considering the growth prospects in emerging markets, various companies, such as Baxter, B. Braun Melsungen AG., Fresenius Kabi, and several others, are competing to capture the maximum share in emerging markets.
Marketplace discussions related to elastomeric infusion pumps indicate that portable regional anaesthesia applications exhibit large untapped opportunities for elastomeric pump manufacturers, and this trend is widely observed in the U.S. elastomeric infusion pumps market in ambulatory care centres, dental care units, and cancer care centres.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Greater attention toward evidence-backed treatments
The caregiving model across the world is changing into an evidence-backed system for the better tracking of capital flow, the progress of patients, and reducing the duration of hospital stays. One of the most important requirements of evidence-backed treatment is found in Acute Pain Service (APS). During marketplace discussions, most hospitals showed preference toward the usage of elastomeric infusion pumps instead of electronic ambulatory pumps and patient-controlled analgesia pumps for pain management.
The primary factors were ease of usage, low cost, discreteness, fewer issues, and less chances of fatalities. These factors are leading to an increase in the number of hospitals floating tenders for the procurement of better-quality elastomeric infusion pumps, and this trend is being observed in developed and developing markets in North America, Asia Pacific, and Europe.
Thus, growing awareness regarding evidence-backed treatment is expected to fuel the growth of the elastomeric infusion pumps market during the forecast period.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Frequent product recalls and reported errors
An approximate of 56,000 reports_bk_01_01_2020 of opposing events linked with the usage of elastomeric infusion pumps, which include numerous deaths and injuries, was received by the U.S. FDA during 2005–2009. Of these, elastomeric infusion pumps accounted for only 2.8% of the overall adverse effects reported.
However, the U.S. FDA has become more stringent with regards to the clearance process of elastomeric infusion pumps, thus leading to longer mark-to-market timings and product recalls & rejections. This is expected to hamper the revenue flows of manufacturers operating in the elastomeric infusion pumps market.
Elastomeric infusion pumps are among the most recalled medical devices due to design deficiencies. Other errors associated with these pumps include software problems, alarm errors, inadequate user interface design (human factor issues), damaged components, battery failure, fire, sparks, charring, or electric shocks, which is likely to hamper the growth of the elastomeric infusion pumps market throughout the forecast period.
Explore Persistence Market Research’s expertise in promulgation of the business !
Elastomeric infusion pumps, which are also referred to as balloon pumps, are used as medical aids for the administration of liquid drugs such as analgesics, local anesthetics, antibiotics, or cytostatics, based on the treatment therapy.
The required pressure to administer the drug is generated from the balloon/elastomeric layer that is molded inside elastomeric infusion pumps. This layer is stretched when elastomeric infusion pumps are filled. The elastic constriction leads the liquid via tubing and gradually through a flow restrictor out into the patient connection.
About the Report
PMR conducted a research study on the elastomeric infusion pumps market for the forecast period 2019 to 2030. The report offers a comprehensive evaluation of the business opportunities prevailing in the elastomeric infusion pumps market, along with insights on the elastomeric infusion pumps market value analysis based on the region, global & regional market trends, pricing analysis based on product type, regulatory scenario, macro-economic factors, industry insights, pricing analysis by vendors, new disease indication forecast analysis, hazard analysis, and volume analysis by vendors.
The elastomeric infusion pumps market report elaborates the macro-economic factors influencing the dynamics of the market and its futuristic potential.
Elastomeric Infusion Pumps Market: Segmentation
The report on the elastomeric infusion pumps market offers a comprehensive taxonomy of the market for elastomeric infusion pumps based on product type, treatment type, distribution channel, and region. By product type, the elastomeric infusion pumps market is segmented into variable rate elastomeric infusion pumps and continuous rate elastomeric infusion pumps.
By treatment type, the elastomeric infusion pumps market is segmented into antibiotic/antiviral, pain management, chemotherapy, and others. The others segment is sub-segmented into chelation therapy and nutrition intake. By distribution channel type, the elastomeric infusion pumps market is segmented into hospitals, ambulatory surgical centers, home care settings, clinics, and others.
By region, the elastomeric infusion pumps market is segment into North America, Latin America, Europe, APAC, and Middle East & Africa.
Additional Questions Answered
Some of the additional questions addressed in this report on the elastomeric infusion pumps market are:
- What is the revenue potential of the elastomeric infusion pumps market across the regions of North America and Europe?
- Who are the key competitors and what are their portfolios in the elastomeric infusion pumps market?
- What are the major challenges influencing the growth of the elastomeric infusion pumps market?
- How is the intervention of regulatory authorities shaping the growth of the elastomeric infusion pumps market?